{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T11:27:43Z","timestamp":1773833263433,"version":"3.50.1"},"reference-count":28,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1016\/j.transproceed.2009.08.065","type":"journal-article","created":{"date-parts":[[2009,12,11]],"date-time":"2009-12-11T15:11:32Z","timestamp":1260544292000},"page":"4138-4146","source":"Crossref","is-referenced-by-count":14,"title":["Renal Function Outcomes in Kidney Transplant Recipients After Conversion to Everolimus-Based Immunosuppression Regimen with CNI Reduction or Elimination"],"prefix":"10.1016","volume":"41","author":[{"given":"A.","family":"Cataneo-D\u00e1vila","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Z\u00fa\u00f1iga-Varga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Correa-Rotter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Alber\u00fa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2009.08.065_bib1","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1056\/NEJMra011295","article-title":"Strategies to improve long-term outcomes after renal transplantation","volume":"346","author":"Pascual","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.transproceed.2009.08.065_bib2","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1053\/j.ajkd.2004.04.003","article-title":"Transplant: immunology and treatment of rejection","volume":"43","author":"Davis","year":"2004","journal-title":"Am J Kidney Dis"},{"issue":"suppl 3","key":"10.1016\/j.transproceed.2009.08.065_bib3","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.1097\/00007890-200505153-00001","article-title":"Reduction in calcineurin inhibitor exposure and maintenance of effective immunosuppression: clinical experience with everolimus (Certican) [Editorial]","volume":"79","author":"Monaco","year":"2005","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2009.08.065_bib4","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1111\/j.1600-6143.2008.02159.x","article-title":"Banff 07 classification of renal allograft pathology: update and future directions","volume":"8","author":"Solez","year":"2008","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2009.08.065_bib5","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1097\/00075198-200112000-00003","article-title":"Nephrotoxicity of immunosuppressive drugs: new insight and preventive strategies","volume":"7","author":"Olyaei","year":"2001","journal-title":"Curr Opin Crit Care"},{"issue":"suppl 3","key":"10.1016\/j.transproceed.2009.08.065_bib6","doi-asserted-by":"crossref","first-page":"S72","DOI":"10.1097\/01.TP.0000162436.17526.0F","article-title":"Introducing everolimus (Certican) in organ transplantation: an overview of preclinical and early clinical developments","volume":"79","author":"Neumayer","year":"2005","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2009.08.065_bib7","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/00007890-199707150-00008","article-title":"SDZ RAD, a new rapamycin derivative: pharmacological properties in vitro and in vivo","volume":"64","author":"Schuler","year":"1997","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2009.08.065_bib8","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S1471-4892(03)00071-7","article-title":"Targeting mTOR signaling for cancer therapy","volume":"3","author":"Huang","year":"2003","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.transproceed.2009.08.065_bib9","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1517\/13543784.14.3.313","article-title":"Inhibitors of the mammalian target of rapamycin","volume":"14","author":"Dancey","year":"2005","journal-title":"Exp Opin Invest Drugs"},{"key":"10.1016\/j.transproceed.2009.08.065_bib10","doi-asserted-by":"crossref","first-page":"861","DOI":"10.2165\/00003495-200464080-00005","article-title":"Everolimus","volume":"64","author":"Chapman","year":"2004","journal-title":"Drugs"},{"key":"10.1016\/j.transproceed.2009.08.065_bib11","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/00007691-200202000-00010","article-title":"Early clinical experience with a novel rapamycin derivative","volume":"24","author":"Nashan","year":"2002","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.transproceed.2009.08.065_bib12","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1034\/j.1399-0012.2002.01119.x","article-title":"Calcineurin inhibitor nephrotoxicity: reduction in dose results in marked improvement in renal function in patients with coexisting chronic allograft nephropathy","volume":"16","author":"Pilmore","year":"2002","journal-title":"Clin Transplant"},{"key":"10.1016\/j.transproceed.2009.08.065_bib13","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1046\/j.1523-1755.2001.0590041567.x","article-title":"Long-term impact of discontinued or reduced calcineurin inhibitor in patients with chronic allograft nephropathy","volume":"59","author":"Weir","year":"2001","journal-title":"Kidney Int"},{"key":"10.1016\/j.transproceed.2009.08.065_bib14","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1111\/j.1600-6143.2004.00590.x","article-title":"Predictors of success in conversion from calcineurin inhibitor to sirolimus in chronic allograft dysfunction","volume":"4","author":"Diekmann","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2009.08.065_bib15","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/TP.0b013e3181927a41","article-title":"Conversion from calcineurin inhibitors to sirolimus maintenance therapy in renal allograft recipients: 24-month efficacy and safety results from the CONVERT trial","volume":"87","author":"Schena","year":"2009","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2009.08.065_bib16","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1399-0012.2005.00326.x","article-title":"Therapeutic drug monitoring for everolimus in kidney transplantation using 12-month exposure, efficacy and safety data","volume":"19","author":"Lorber","year":"2005","journal-title":"Clin Transplant"},{"key":"10.1016\/j.transproceed.2009.08.065_bib17","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/j.1399-0012.2008.00795.x","article-title":"Early, abrupt conversion of de novo renal transplant patients from cyclosporine to everolimus: results of a pilot study","volume":"22","author":"Holdaas","year":"2008","journal-title":"Clin Transplant"},{"key":"10.1016\/j.transproceed.2009.08.065_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.trre.2005.10.005","article-title":"Everolimus (Certican) in renal transplantation: a review of clinical trial data, current usage and future directions","volume":"20","author":"Pascual","year":"2006","journal-title":"Transplant Rev"},{"key":"10.1016\/j.transproceed.2009.08.065_bib19","doi-asserted-by":"crossref","first-page":"S97","DOI":"10.1016\/S0272-6386(00)70237-X","article-title":"Proteinuria: its clinical importance and role in progressive kidney disease","volume":"35","author":"Keane","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.transproceed.2009.08.065_bib20","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1093\/ndt\/gfh957","article-title":"Long-term results in renal transplant patients with allograft dysfunction after switching from calcineurin inhibitors to sirolimus","volume":"20","author":"Bumbea","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.transproceed.2009.08.065_bib21","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1097\/01.tp.0000184623.35773.6a","article-title":"Conversion from cyclosporine to sirolimus in stable renal transplant recipients","volume":"80","author":"Sennesael","year":"2005","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2009.08.065_bib22","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1161\/01.HYP.29.1.222","article-title":"Afferent and efferent arteriolar vasoconstriction to angiotensin II and norepinephrine involves release of Ca2+ from intracellular stores","volume":"29","author":"Inscho","year":"1997","journal-title":"Hypertension"},{"key":"10.1016\/j.transproceed.2009.08.065_bib23","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.transproceed.2006.12.026","article-title":"Conversion from a calcineurin inhibitor-based immunosuppresive regimen to everolimus in renal transplant recipients: effect on renal function and proteinuria","volume":"39","author":"Morales","year":"2007","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2009.08.065_bib24","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1111\/j.1600-6143.2007.02010.x","article-title":"Respective predictive role of urinary albumin excretion and nonalbumin proteinuria on graft loss and death in renal transplant recipients","volume":"7","author":"Halimi","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2009.08.065_bib25","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1097\/01.TP.0000116413.50765.F2","article-title":"Combination therapy with sirolimus and mycophenolate mofetil: effects on the kidney and on transforming growth factor-[beta] 1","volume":"77","author":"Shihab","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2009.08.065_bib26","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1046\/j.1600-6143.2003.00337.x","article-title":"Enteric-coated mycophenolate sodium is therapeutically equivalent to mycophenolate mofetil in de novo renal transplant patients","volume":"4","author":"Salvadori","year":"2003","journal-title":"Am J Transplant"},{"issue":"suppl 3","key":"10.1016\/j.transproceed.2009.08.065_bib27","doi-asserted-by":"crossref","first-page":"iii24","DOI":"10.1093\/ndt\/gfl301","article-title":"Conversion to everolimus in maintenance patients: current clinical strategies","volume":"21","author":"Pohanka","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.transproceed.2009.08.065_bib28","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/00007890-199907270-00018","article-title":"A randomized double-blind, multicenter plasma concentration controlled study of the safety and efficacy of oral mycophenolate mofetil for the prevention of acute rejection after kidney transplantation","volume":"68","author":"Van Gelder","year":"1999","journal-title":"Transplantation"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134509013451?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134509013451?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,14]],"date-time":"2018-12-14T18:51:35Z","timestamp":1544813495000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134509013451"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12]]},"references-count":28,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["S0041134509013451"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2009.08.065","relation":{},"ISSN":["0041-1345"],"issn-type":[{"value":"0041-1345","type":"print"}],"subject":[],"published":{"date-parts":[[2009,12]]}}}